Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Early antibiotics may shield trauma patients from ventilator pneumonia

NCT ID NCT07059039

First seen Oct 31, 2025 · Last updated Jun 19, 2026 · Updated 33 times

Summary

This completed study looked at whether giving antibiotics early to trauma patients on breathing machines can prevent ventilator-associated pneumonia (VAP). Researchers analyzed data from 2,143 adults admitted for severe trauma between 2021 and 2023. The goal was to see if this simple preventive step reduces early pneumonia cases without causing harm.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA (VAP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hopital Beaujon

    Clichy, 92110, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

antibiotics (antibiotic prophylaxis)

What this could lead to

If effective, this approach could reduce pneumonia rates in trauma patients on ventilators, potentially saving lives and shortening hospital stays.

What could go wrong

The study is completed but results are not yet published. Antibiotic overuse may lead to resistant bacteria, and benefits may not apply to all trauma patients.

Conditions

The condition(s) this trial relates to.

injury pneumonia Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.